These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1661036)

  • 1. Quo vadis? The clinical dilemma of simultaneous cytomegalovirus infection and steroid-resistant rejection.
    van den Berg AP; Tegzess AM; Scholten-Sampson A; van der Giessen M; The TH; van Son WJ
    Transplantation; 1991 Dec; 52(6):1081-3. PubMed ID: 1661036
    [No Abstract]   [Full Text] [Related]  

  • 2. Preemptive therapy with gancyclovir for early high-risk CMV infection allows effective treatment with antithymocyte globulin of steroid-resistant rejection after renal transplantation.
    van Son WJ; van den Berg AP; The TH; Tegzess AM
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1436-8. PubMed ID: 8382873
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased frequency of kidney allograft rejection in recipients with cyclosporine and/or steroid-resistant lymphoid responses.
    Bowes LG; Dumble LJ; Francis DM; Macdonald IM; Clunie GJ; Kincaid-Smith P
    Transplant Proc; 1990 Oct; 22(5):2139-40. PubMed ID: 2145672
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytomegalovirus infection in pediatric kidney transplantation.
    Fontana I; Verrina E; Timitilli A; Arcuri V; Basile G; Losurdo G; Rabagliati AM; Perfumo F; Giacchino R; Gusmano R
    Transplant Proc; 1994 Feb; 26(1):18-9. PubMed ID: 8108929
    [No Abstract]   [Full Text] [Related]  

  • 5. Ganciclovir treatment for cytomegalovirus infections in renal transplant recipients.
    Buturović-Ponikvar J; Kandus A; Malovrh M; Ponikvar R; Kveder R
    Transplant Proc; 1992 Oct; 24(5):1921-3. PubMed ID: 1329287
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytomegalovirus prophylaxis in pediatric renal transplant recipients.
    So S; Mayo C; McCullough C; Jendrisak M; Woodle S; Marsh W; Bailey T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1414-5. PubMed ID: 8382865
    [No Abstract]   [Full Text] [Related]  

  • 7. Ganciclovir prophylaxis to prevent CMV disease in kidney recipients undergoing anti-lymphocyte globulin treatment for acute rejection.
    Dickenmann MJ; Kabulbayev K; Steiger J; Cathomas G; Reusser P; Tamm M
    Clin Microbiol Infect; 2004 Apr; 10(4):337-9. PubMed ID: 15059125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy.
    Morales E; Andrés A; González E; Herrero JC; Muñoz MA; Ortiz M; Espejo B; Lumbreras C; Morales JM; Aguado JM
    Transplant Proc; 2002 Feb; 34(1):73-4. PubMed ID: 11959191
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.
    Turgeon N; Fishman JA; Basgoz N; Tolkoff-Rubin NE; Doran M; Cosimi AB; Rubin RH
    Transplantation; 1998 Dec; 66(12):1780-6. PubMed ID: 9884276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus prophylaxis in antibody-treated renal transplanted patients.
    Birkeland S; Gahrn-Hansen B; Andersen H; Rohr N; Larsen KE; Jørgensen A
    Transplant Proc; 1995 Dec; 27(6):3473-6. PubMed ID: 8540056
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of renal allograft rejection in the presence of cytomegalovirus disease. A report of two cases.
    Burns KD; Johnson-Whittaker L; Couture RA; Eidus L; Garber G
    Am J Nephrol; 1990; 10(2):162-6. PubMed ID: 2161616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
    Prieto C; Rodriguez-Paternina E; Andrés A; Morales JM; Farias J; Montoyo C; Regueiro JR; Rodicio JL
    Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
    [No Abstract]   [Full Text] [Related]  

  • 13. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial.
    Hibberd PL; Tolkoff-Rubin NE; Conti D; Stuart F; Thistlethwaite JR; Neylan JF; Snydman DR; Freeman R; Lorber MI; Rubin RH
    Ann Intern Med; 1995 Jul; 123(1):18-26. PubMed ID: 7762909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice of antibody immunotherapy influences cytomegalovirus viremia in simultaneous pancreas-kidney transplant recipients.
    Huurman VA; Kalpoe JS; van de Linde P; Vaessen N; Ringers J; Kroes AC; Roep BO; De Fijter JW
    Diabetes Care; 2006 Apr; 29(4):842-7. PubMed ID: 16567825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
    Said T; Nampoory MR; Johny KV; Pacsa AS; Mini Abraham P; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
    Transplant Proc; 2004; 36(6):1847-9. PubMed ID: 15350495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preemptive versus sequential prophylactic-preemptive treatment regimens for cytomegalovirus in renal transplantation: comparison of treatment failure and antiviral resistance.
    van der Beek MT; Berger SP; Vossen AC; van der Blij-de Brouwer CS; Press RR; de Fijter JW; Claas EC; Kroes AC
    Transplantation; 2010 Feb; 89(3):320-6. PubMed ID: 20145523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The high failure rate of OKT3 in the treatment of acute renal allograft rejection resistant to steroids with or without antithymocyte globulin.
    Davies SP; Brown EA; Woodrow DF; Phillips ME; Gower PE; Mee AD
    Transplantation; 1991 Oct; 52(4):746-9. PubMed ID: 1926361
    [No Abstract]   [Full Text] [Related]  

  • 18. Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence?
    Melzer JS; Husing RM; Feduska NJ; Tomlanovich SJ; Vincenti F; Amend WJ; Garovoy M; Salvatierra O
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1971-3. PubMed ID: 2856274
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymoglobulin Versus Basiliximab Induction Therapy in Low-Risk Kidney Transplant Recipients: A Single-Center Experience.
    Lee H; Lee S; Jeon JS; Kwon SH; Noh H; Han DC; Yun S; Song D
    Transplant Proc; 2018 Jun; 50(5):1285-1288. PubMed ID: 29880348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.